MIRM · Mirum Pharmaceuticals, Inc.
$100.64
+1.87 (+1.89%)
At close · Aug 14
Market Cap
$6.53B
Shares
64.93M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-18 | 2026-06-15 | |
| 8-K | 2026-05-18 | 2026-05-12 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| 8-K | 2026-05-04 | — | |
| 8-K | 2026-04-27 | — | |
| DEF 14A | 2026-04-23 | 2025-12-31 | |
| 8-K/A | 2026-04-08 | 2026-01-23 | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-01-26 | 2026-01-23 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-19 | — | |
| 8-K | 2025-12-19 | 2025-12-18 | |
| 8-K | 2025-12-08 | 2025-12-06 | |
| 8-K | 2025-11-17 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-05-30 | 2025-05-29 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-14 | — | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-06-17 | — | |
| 8-K | 2024-06-06 | 2024-06-05 | |
| 8-K | 2024-05-31 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-23 | — | |
| 10-K | 2024-03-15 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-01-16 | 2024-01-11 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-18 | — | |
| 8-K/A | 2023-11-02 | 2023-08-31 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-10-17 | — | |
| 8-K | 2023-10-13 | — |
Showing 1–50 of 114 filings
Key facts
CIK
1759425
CUSIP
604749101
13F (30d)
320 filings
314 filers
Visit website
Investor relations